House Energy Subcommittee Sets Hearing on Drug Pricing Transparency
May 18, 2019
May 18, 2019
WASHINGTON, May 18 -- The House Energy and Commerce subcommittee on Health issued the following hearing information: Improving drug pricing transparency and lowering prices for American consumers at 2123 Rayburn House Office Building at 10:30 a.m. on May 21:
Key Documents
Legislation
* H.R. 2069, the "Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act," or the "SPIKE Act"
* H.R. 2115, the "Public Disc . . .
Key Documents
Legislation
* H.R. 2069, the "Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act," or the "SPIKE Act"
* H.R. 2115, the "Public Disc . . .